Concepedia

Publication | Open Access

<i>ARID5B</i> Influences Antimetabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia

DOIFull Paper Access

36

Citations

45

References

2019

Year

Heng Xu, Xujie Zhao, Deepa Bhojwani, E Shuyu, Charnise Goodings, Hui Zhang, Nita L. Seibel, Wentao Yang, Chunliang Li, William L. Carroll,
Clinical Cancer Research

Abstract

Our data indicate that ARID5B is an important molecular determinant of antimetabolite drug sensitivity in ALL, in part, through p21-mediated effects on cell-cycle progression.

References

YearCitations

Page 1